Prostatype Genomics AB Free Cash Flow Generation Index
Latest as of June 2020:
0.94x
Prostatype Genomics AB free cash flow generation index. Prostatype Genomics AB (PROGEN) has a Free Cash Flow Generation Index of 0.94x as of June 2020. Free cash flow of Skr5.27 Million represents 1% of operating cash flow (Skr5.63 Million).
FCF Generation Index
0.94x
Free Cash Flow / Operating CF
Free Cash Flow
Skr5.27 Million
SEK
Operating Cash Flow
Skr5.63 Million
SEK
Capital Expenditures
Skr361.71K
SEK
Prostatype Genomics AB Free Cash Flow Generation Index by Year (None–None)
Prostatype Genomics AB free cash flow generation index by year from None to None. Year-by-year Free Cash Flow Generation Index for Prostatype Genomics AB. For the full cash flow conversion analysis, see PROGEN cash flow metrics.
| Year | FCG Index | Free Cash Flow (SEK) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).